These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2599104)

  • 1. S-phase inhibitors induce vimentin expression in human promonocytic U-937 cells.
    Mata F; Rius C; Cabañas C; Bernabeu C; Aller P
    FEBS Lett; 1989 Dec; 259(1):171-4. PubMed ID: 2599104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of human promonocytic leukemia U-937 cells with DNA topoisomerase II inhibitors: induction of vimentin gene expression.
    Rius C; Zorrilla AR; Cabañas C; Mata F; Bernabeu C; Aller P
    Mol Pharmacol; 1991 Apr; 39(4):442-8. PubMed ID: 1850089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential modulation of the expression of the intermediate filament proteins vimentin and nuclear lamins A and C by differentiation inducers in human myeloid leukemia (U-937, HL-60) cells.
    Rius C; Vilaboa N; Mata F; Aller P
    Exp Cell Res; 1993 Sep; 208(1):115-20. PubMed ID: 8395394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The induction of vimentin gene expression by sodium butyrate in human promonocytic leukemia U937 cells.
    Rius C; Cabañas C; Aller P
    Exp Cell Res; 1990 May; 188(1):129-34. PubMed ID: 2328771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vimentin expression as a late event in the in vitro differentiation of human promonocytic cells.
    Rius C; Aller P
    J Cell Sci; 1992 Feb; 101 ( Pt 2)():395-401. PubMed ID: 1352781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Camptothecin induces differentiation and stimulates the expression of differentiation-related genes in U-937 human promonocytic leukemia cells.
    Aller P; Rius C; Mata F; Zorrilla A; Cabañas C; Bellón T; Bernabeu C
    Cancer Res; 1992 Mar; 52(5):1245-51. PubMed ID: 1737386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of LFA-1-mediated homotypic adhesions in promonocytic U-937 cells occurs independently of cell differentiation.
    Cabañas C; Lastres P; Bellón T; Aller P; Figdor CG; Corbi A; Bernabeu C
    Biochim Biophys Acta; 1991 Apr; 1092(2):165-8. PubMed ID: 1673351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apolipoprotein E expression during erythroid differentiation of human K562 leukemia cells.
    Crespo P; Delgado MD; Gómez-Casares MT; Cuadrado MA; Richard C; León J
    Leuk Res; 1993 Sep; 17(9):771-6. PubMed ID: 8371577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of cytoskeletal vimentin and actin gene expression by a tumor-promoting phorbol ester in the human leukemic cell line K562.
    Siebert PD; Fukuda M
    J Biol Chem; 1985 Mar; 260(6):3868-74. PubMed ID: 3838316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric correlation of the c-myc oncoprotein and cell cycle kinetics of HL60 leukaemia during induced maturation with cytosine arabinoside and dimethylsulphoxide.
    Dent GA; Ayscue LH; High KA; Leglise MC; Ross DW
    Cell Tissue Kinet; 1989 Jan; 22(1):1-11. PubMed ID: 2676187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of c-myc gene is not obligatory for growth inhibition and differentiation of human myeloid leukemia cells.
    Gómez-Casares MT; Delgado MD; Lerga A; Crespo P; Quincoces AF; Richard C; León J
    Leukemia; 1993 Nov; 7(11):1824-33. PubMed ID: 8231250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional repression of vimentin gene expression by pyrroline dithiocarbamate during 12-O-tetradecanoylphorbol-13-acetate-dependent differentiation of HL-60 cells.
    Zheng M; Son MY; Park C; Park JI; Jo EK; Yoon WH; Park SK; Hwang BD; Lim K
    Oncol Rep; 2005 Sep; 14(3):713-7. PubMed ID: 16077980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of vimentin expression and protease-mediated vimentin degradation during differentiation of human monocytic leukemia cells.
    Honke K; Wada Y
    Jpn J Cancer Res; 1997 May; 88(5):484-91. PubMed ID: 9247605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of c-jun gene expression by arabinofuranosylcytosine in human myeloid leukemia cells.
    Kharbanda SM; Sherman ML; Kufe DW
    J Clin Invest; 1990 Nov; 86(5):1517-23. PubMed ID: 2122980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937).
    Vrana JA; Saunders AM; Chellappan SP; Grant S
    Differentiation; 1998 May; 63(1):33-42. PubMed ID: 9615391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of vimentin and nuclear lamins during the in vitro differentiation of human promyelocytic leukemia cells HL-60.
    Paulin-Levasseur M; Giese G; Scherbarth A; Traub P
    Eur J Cell Biol; 1989 Dec; 50(2):453-61. PubMed ID: 2697560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of cell growth-dependent gene transcript levels by sodium butyrate in serum stimulated fibroblasts.
    Aller P; Hirschhorn RR; Rius C
    Biochem Int; 1989 Jan; 18(1):119-27. PubMed ID: 2719709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible differentiation of human monoblastic leukemia U937 cells by ML-9, an inhibitor of myosin light chain kinase.
    Yamamoto-Yamaguchi Y; Makishima M; Kanatani Y; Kasukabe T; Honma Y
    Exp Hematol; 1996 May; 24(6):682-9. PubMed ID: 8635523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid effect on lipocortin mRNA expression in U-937 cells.
    Solito E; Raugei G; Melli M; Parente L
    Pharmacol Res; 1992; 25 Suppl 1():13-4. PubMed ID: 1387211
    [No Abstract]   [Full Text] [Related]  

  • 20. The action of the DNA intercalating agents 4'-(9-acridinylamino) methanesulphon-m-anisidide and 1,4-bis(butylamino) benzo[g]phthalazine in U-937 human promonocytic cells: relationship between cell cycle and differentiation.
    Pérez C; Campayo L; Navarro P; García-Bermejo L; Aller P
    Biochem Pharmacol; 1994 Jul; 48(1):75-82. PubMed ID: 7519013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.